首页> 美国卫生研究院文献>BMJ Open Access >Bimatoprost 0.03 preservative-free ophthalmic solution versus bimatoprost 0.03 ophthalmic solution (Lumigan) for glaucoma or ocular hypertension: a 12-week randomised double-masked trial

【2h】

Bimatoprost 0.03 preservative-free ophthalmic solution versus bimatoprost 0.03 ophthalmic solution (Lumigan) for glaucoma or ocular hypertension: a 12-week randomised double-masked trial

机译：比马前列素0.03％无防腐剂眼药水与比马前列素0.03％眼药水（Lumigan）用于青光眼或高眼压症：一项为期12周的随机双掩盖试验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background/AimTo evaluate efficacy and safety of bimatoprost 0.03% preservative-free (PF) ophthalmic solution versus bimatoprost 0.03% (Lumigan) ophthalmic solution for glaucoma or ocular hypertension.

机译：背景/目的为了评估比马前列素0.03％（Lumigan）眼用溶液比马前列素0.03％无防腐剂（PF）眼药水对青光眼或高眼压的疗效和安全性。

著录项

期刊名称 BMJ Open Access
作者
Douglas G Day; Thomas R Walters; Gail F Schwartz; Thomas K Mundorf; Charlie Liu; Rhett M Schiffman; Marina Bejanian;
展开▼
作者单位

展开▼
年(卷),期 -1(97),8
年度 -1
页码 989–993
总页数 5
原文格式 PDF
正文语种
中图分类
关键词
Glaucoma Treatment Medical Ocular surface Intraocular pressure;

机译：青光眼;医学治疗;眼表;眼压;

相似文献

外文文献
中文文献
专利

1. Bimatoprost 0.03% preservative-free ophthalmic solution versus bimatoprost 0.03% ophthalmic solution (Lumigan) for glaucoma or ocular hypertension: A 12-week, randomised, double-masked trial [J] . DayD.G., WaltersT.R., SchwartzG.F., British journal of ophthalmology . 2013,第8期

机译：比马前列素0.03％无防腐剂眼药水与比马前列素0.03％眼药水（Lumigan）用于青光眼或高眼压症：一项为期12周的随机双掩盖试验
2. Bimatoprost 0.03%/timolol 0.5% preservative-free ophthalmic solution versus bimatoprost 0.03%/timolol 0.5% ophthalmic solution (Ganfort) for glaucoma or ocular hypertension: A 12-week randomised controlled trial [J] . GoldbergI., GilPinaR., Lanzagorta-ArestiA., British journal of ophthalmology . 2014,第7期

机译：比马前列素0.03％/替莫洛尔0.5％不含防腐剂的眼药水与比马前列素0.03％/替莫洛尔0.5％眼药水（Ganfort）用于青光眼或高眼压症：一项为期12周的随机对照试验
3. Long-term safety evaluation of bimatoprost ophthalmic solution 0.03%: a pooled analysis of six double-masked, randomized, active-controlled clinical trials [J] . David Wirta, Amanda M VanDenburgh, Emily Weng, Clinical ophthalmology . 2011,第9期

机译：比马前列素滴眼液0.03％的长期安全性评估：六项双掩蔽，随机，主动对照临床试验的汇总分析
4. Prior Prostaglandin Agonist Exposure and Conjunctival Hyperemia with Bimatoprost 0.03 Preservative-Free and Bimatoprost 0.03 Solutions in a Randomized, Multicenter Study [C] . Bejanian M., Liu C-C, Schiffman R. International Symposium on Ocular Pharmacology and Therapeutics . 2013

机译：先前前列腺素激动剂暴露和结膜充血与Bimatoprost 0.03％无保存和双咪替其前列素在随机的，多中心研究中的0.03％溶液
5. Bimatoprost 0.03/timolol 0.5 preservative-free ophthalmic solution versus bimatoprost 0.03/timolol 0.5 ophthalmic solution (Ganfort) for glaucoma or ocular hypertension: a 12-week randomised controlled trial [O] . Ivan Goldberg, Rafael Gil Pina, Aitor Lanzagorta-Aresti, -1

机译：比马前列素0.03％/替莫洛尔0.5％不含防腐剂的眼药水与比马前列素0.03％/替莫洛尔0.5％眼药水（Ganfort）用于青光眼或高眼压症：一项为期12周的随机对照试验
6. Long-term safety evaluation of bimatoprost ophthalmic solution 0.03%: a pooled analysis of six double-masked, randomized, active-controlled clinical trials [O] . Wirta, David, VanDenburgh, Amanda M, Weng, Emily, 2011

机译：比马前列素滴眼液0.03％的长期安全性评估：六项双掩蔽，随机，主动对照临床试验的汇总分析

Bimatoprost 0.03 preservative-free ophthalmic solution versus bimatoprost 0.03 ophthalmic solution (Lumigan) for glaucoma or ocular hypertension: a 12-week randomised double-masked trial

摘要

著录项

相似文献

相关主题

期刊订阅